Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection. [electronic resource]
Producer: 20190920Description: 286-292 p. digitalISSN:- 1600-0641
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Antiviral Agents -- therapeutic use
- Biomarkers -- blood
- DNA, Viral -- blood
- Female
- Hepatitis B -- complications
- Hepatitis B Antibodies -- blood
- Hepatitis B Surface Antigens -- blood
- Hepatitis B virus -- physiology
- Humans
- Lymphoma, Non-Hodgkin -- complications
- Male
- Middle Aged
- Predictive Value of Tests
- Risk Assessment -- methods
- Rituximab -- therapeutic use
- Taiwan
- Virus Activation -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.